Quantcast

BioCollections Worldwide, Inc.(TM) Opens Doors to Extensive Bio-Inventory

January 23, 2014

Hundreds of thousands of fully characterized clinical specimen now available for research and product development needs

MIAMI, Jan. 23, 2014 /PRNewswire-iReach/ — BioCollections Worldwide, Inc. (“BCW”) announced today the release of over 200,000 clinically characterized specimen available for research and development purposes. For over 13 years, BCW has been performing Blood Collection Protocols (BCPs) for infectious diseases and other clinical diagnostic markets. These protocols have been performed at BCW’s worldwide subsidiaries as well as through its network of collection partners.

(Photo: http://photos.prnewswire.com/prnh/20140123/MN51234)

“After 13 years of performing BCPs in different parts of the world, we are now opening our Bio-Inventory doors to our extensive inventory of highly characterized samples.” said Sixto Pacheco, President & CEO. “Our BCPs have been performed throughout the world, achieving biodiversity in sample availability utilizing high quality standards throughout the collection, transport and testing processes.” Pacheco continued.

BCW currently holds a wide-ranged inventory of plasma, serum and other matrices that have been assayed and characterized using FDA and IVD clinical diagnostic products. These matrices have been collected globally and include rare subtypes and genotypes of Human Immunodeficiency Virus (HIV) and Hepatitis in addition to other infectious disease markers.

BCW also operates its own CLIA certified and COLA accredited clinical laboratory with numerous capabilities including molecular diagnostics, virology and serology testing. The laboratory is staffed with medical technologists and operates multiple shifts to meet demanding turn-around times. This laboratory operates BCW’s bio-mining program, which further tests specimen for other disease states and clinical markers.

###

About BCW:

BioCollections Worldwide, Inc. (BCW), established in 2000, has been at the forefront of providing customized solutions for the development of new and emerging in vitro Diagnostics, Medical Devices, Life Sciences and Biopharmaceutical products. BCW provides clinical operations services, specimen storage and clinical testing. The Company also offers products to validate, monitor and troubleshoot molecular assays. BCW is headquartered in Miami, FL with multiple satellite offices in Europe and Africa.

https://www.biocollections.com

info@biocollections.com

(305) 792-2090

Twitter: @biocollections

Facebook: facebook.com/biocollections

Media Contact: Liberty Woods, BioCollections Worldwide, Inc., 305-792-2090, lwoods@biocollections.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE BioCollections Worldwide, Inc.


Source: PR Newswire



comments powered by Disqus